CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

EyePoint Pharmaceuticals - CapyFin

EyePoint Pharmaceuticals

EYPT · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 3 months ago

Previous year: $11.7M

Previous year: -$0.55

Research and development

Previous year: $30.1M

Total operating expenses

Previous year: $45M

Sales and marketing

Previous year: $6K

Cash and Equivalents

Previous year: $299M

Previous year: $329M

Loading...

Key Statistics

Market Cap

$1.12B

P/E Ratio

-5.50

Sector

N/A

Industry

N/A

52-Week High

$18.8

52-Week Low

$4.11

Research and development

$58.6M

Total operating expenses

$73.3M

Sales and marketing

$35K

General and administrative

$13.9M

EyePoint Pharmaceuticals

Unlock previous datapoints

EyePoint Pharmaceuticals

Unlock previous datapoints

EyePoint Pharmaceuticals Revenue by Segment

Revenue by Segment

Product sales, net Revenue

Unlock previous datapoints

CapyFin.com

License and royalties Revenue

Unlock previous datapoints

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...